BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension

  Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension.

  June 8, 2022

   · 

  6 min read
• Pharm Country

  Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and Progress Against Public Commitments

  Johnson & Johnson published its 2021 Health for Humanity Report, which shares progress against its purpose-driven Health for Humanity 2025 Goals and serves as its annual disclosure on environmental, social and governance performance.

  June 8, 2022

   · 

  9 min read
• Genetown

  Glympse to Present Two Posters Demonstrating Novel Protease Biosensor Diagnostic Platform Detection of Hepatocellular Carcinoma at EASL ILC 2022

  Glympse to Present Two Posters Demonstrating Novel Protease Biosensor Diagnostic Platform Detection of Hepatocellular Carcinoma at EASL ILC 2022.

  June 8, 2022

   · 

  3 min read
• Business

  Ultima Genomics and Olink collaborate to develop solution for high-throughput proteomics

  Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) and Ultima Genomics (“Ultima”) today announced that they have entered into a collaboration to enable the use of the Olink® Explore high-throughput proteomics platform with Ultima’s sequencing architecture.

  June 8, 2022

   · 

  5 min read
• Genetown

  PathAI To Present Three Abstracts at International Liver Congress 2022

  PathAI To Present Three Abstracts at International Liver Congress 2022.

  June 8, 2022

   · 

  4 min read
• FDA

  Vertex Announces Inaxaplin (VX-147) Granted Breakthrough Therapy Designation by U.S. FDA and Priority Medicines (PRIME) Designation by the EMA

  Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has granted inaxaplin (VX-147) Breakthrough Therapy Designation for APOL1-mediated focal segmental glomerulosclerosis (FSGS).

  June 8, 2022

   · 

  7 min read
• BioMidwest

  ENDRA Life Sciences to Participate in the JMP Securities Life Sciences Conference

  ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that management will be participating in the JMP Securities Life Sciences Conference being held June 15-16, 2022 in New York City.

  June 8, 2022

   · 

  1 min read
• Pharm Country

  Proscia’s Concentriq Dx Attains CE Mark Under IVDR For Use In Primary Diagnosis

  Regulatory milestone to accelerate company’s international growth amid expanding presence in Europe.

  June 8, 2022

   · 

  3 min read
• Business

  Inipharm Appoints Chuhan Chung, M.D, as Chief Medical Officer to Advance HSD17B13 Program into the Clinic

  Company to present preclinical metabolomic data on one of its HSD17B13 inhibitors at the International Liver Congress™ 2022.

  June 8, 2022

   · 

  2 min read
• Business

  Gemina Labs Appoints Point-of-Care Diagnostic Executive Brian Firth as Advisor

  Gemina Laboratories Ltd. is pleased to announce the appointment of Brian Firth as an adviser to the Company.

  June 8, 2022

   · 

  4 min read